The case for repatriating the U.S. drug supply

Shortages of many generic drugs have plagued the U.S. health system for decades. The leading cause of drug shortages is quality issues at manufacturing plants, which are mostly located overseas. Some experts argue that bringing pharmaceutical production back to the U.S. will help companies and regulators better monitor manufacturing and avoid issues.

Follow Medically Necessary on Apple Podcasts

Follow Medically Necessary on Spotify

More FreightWaves Podcasts

Learn more about your ad choices. Visit megaphone.fm/adchoices